# NAD+ Oral Supplement Pilot Intervention in Adult Females

> **NCT06579209** · NA · COMPLETED · sponsor: **University of Rhode Island** · enrollment: 53 (actual)

## Conditions studied

- Cognitive Change
- Inflammation
- Neurodegenerative Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Treatment
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06579209
- **Lead sponsor:** University of Rhode Island
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2026-02-20
- **Final completion:** 2026-02-20
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-03-12

## Collaborators

- National Institute of General Medical Sciences (NIGMS)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06579209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06579209, "NAD+ Oral Supplement Pilot Intervention in Adult Females". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT06579209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*